heart failure

Sep 6, 2019

Sphingotec Pushing for Adoption of Novel Acute Care Biomarkers at the Point of Care
Premium

Aug 1, 2019

Ortho Clinical Diagnostics Receives Health Canada Approval for High Sensitivity Troponin I Assay

Jul 23, 2019

Ortho Clinical Diagnostics Receives CE Mark for Enhanced Cardiac Assay

Jun 27, 2019

New Biomarker of Intestinal Permeability Could Lead to Dx for Gut Function
Premium

Jun 11, 2019

More Accurate Heart Failure Diagnostic Test Targeted by Queen's University
Premium

Jun 4, 2019

AMP, CAP Develop Guidelines for CYP2C9 PGX Assay Design
Premium

May 3, 2019

Including Troponin I in Cardiovascular Testing Leads to Earlier Detection of Heart Injury, Study Says
Premium

Apr 16, 2019

High-Sensitivity Troponin Assay From Ortho Clinical Diagnostics CE Marked

Oct 18, 2018

Sphingotec Using €20M Funding Round to Commercialize Critical Care Tests
Premium

Sep 27, 2018

Abbott Troponin Test Receives CE Mark

Jul 25, 2018

FDA Clears Siemens Healthineers High-Sensitivity Troponin Test for Heart Attacks

Jul 11, 2018

Siemens High-Sensitivity Troponin Assay Measures Up to Roche, Abbott Tests, Study Says
Premium

Jun 14, 2018

UK Researchers Eye Alternative POC Test to Troponin to Quickly Rule Out Heart Attack
Premium

May 22, 2018

Sphingotec, Nexus Dx Merge Tech Platforms for POC Testing in ER, ICU

Apr 2, 2018

AACC Publishes High-Sensitivity Troponin Assay Practice Recommendations in Anticipation of More FDA Approvals

Mar 23, 2018

Alere Settles With DOJ for $33.2M

Mar 2, 2018

With £50M Investment, Randox Expects to Push Diagnostics Boundaries
Premium

Feb 1, 2018

Russian Researchers Look to Commercialize New Lateral Flow Immunoassay for Heart Attack, Sepsis
Premium

Dec 7, 2017

Ortho Clinical Diagnostics to Offer Sphingotec Heart Failure Assay

Nov 27, 2017

Beckman Coulter Goes to Court to Sell its BNP Assay